Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2016

Vanda Pharmaceuticals, Inc. (VNDA) Receives Consensus Rating of “Buy”

Posted on November 21, 2016 by MissionIR

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of pharmaceutical products to help in the treatment of central nervous system disorders, now has a product portfolio made up of HETLIOZ® (tasimelteon), Fanapt® (iloperidone), Tradipitant … Continue reading →

Posted in Small Cap News | Leave a comment

Cogint, Inc. (COGT) is “One to Watch”

Posted on November 21, 2016 by MissionIR

Distilling complexity into actionable intelligence is the core focus for recently rebranded data analytics outfit Cogint, Inc. (NASDAQ: COGT). Cogint rang the NASDAQ bell (http://dtn.fm/OTm74) only a handful of days after transitioning shares over to the exchange, amid a big … Continue reading →

Posted in Ones to Watch | Leave a comment

Professional Diversity Network, Inc. (IPDN) Closes Stock Sale Transaction with Cosmic Forward Limited

Posted on November 21, 2016 by MissionIR

In a recent news release by Professional Diversity Network, Inc. (NASDAQ: IPDN), it was announced that Cosmic Forward Limited (“CFL”), a Seychelles-based private company, now owns 51% of the Internet software and services company, which specializes in providing career networking … Continue reading →

Posted in Small Cap News | Leave a comment

Ampio Pharmaceuticals, Inc. (AMPE) Targeting Common Inflammatory Conditions with Two Late-Stage Product Candidates

Posted on November 18, 2016 by MissionIR

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. The company’s development pipeline currently features … Continue reading →

Posted in Small Cap News | Leave a comment

Medical Transcription Billing, Corp. (MTBC) Announces Monthly Dividend on Series A Preferred Stock

Posted on November 18, 2016 by MissionIR

Before the opening bell, Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP) announced that its board of directors has declared monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock for December, January and February. These monthly … Continue reading →

Posted in Medical Transcription Billing, Corp. MTBC | Leave a comment

CytoSorbents Corp. (CTSO) is “One to Watch”

Posted on November 18, 2016 by MissionIR

November has been a promising month for CytoSorbents Corp. (NASDAQ: CTSO), a critical care immunotherapy company. The New Jersey-based company, specializing in blood purification to control deadly inflammation in critically ill and cardiac surgery patients, reported its financial results for … Continue reading →

Posted in Ones to Watch | Leave a comment

Inovio Pharmaceuticals, Inc. (INO) opens New Front Line in War against Cancer & Infectious Diseases with DNA Vaccines

Posted on November 17, 2016 by MissionIR

Over 2,000 years ago, Plato, in his immortal Socratic dialogue, had the great philosopher express his astonishment at the new diseases plaguing Athenian society and their bizarre and horrible names. Our position today is very similar. Strange, horrible afflictions with … Continue reading →

Posted in Small Cap News | Leave a comment

Aegis Capital Supports ‘Buy’ Rating, Higher Stock Price Target for Progenics (PGNX) Following Strong Q3 Results

Posted on November 17, 2016 by MissionIR

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), a company focused on the development of innovative treatments and therapies for cancer, in particular prostate cancer, recently released its financial results for the third quarter of 2016, reporting higher revenue and net income compared … Continue reading →

Posted in Small Cap News | Leave a comment

Nektar Therapeutics (NKTR) is “One to Watch”

Posted on November 17, 2016 by MissionIR

Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical company in the business of developing new medicines for people living with life changing conditions, now helps more than nine million patients worldwide. Nektar also offers a proprietary pipeline made up of drug candidates … Continue reading →

Posted in Ones to Watch | Leave a comment

Monaker Group (MKGI) Set to Capitalize on This Year’s Thanksgiving Celebrations

Posted on November 17, 2016 by MissionIR

This Thanksgiving, AAA, North America’s largest motoring and leisure travel organization, is expecting over one million more Americans to travel. According to the company’s 2016 Thanksgiving Holiday Travel Forecast, there will be more than 48.7 million travelers, marking the highest … Continue reading →

Posted in Monaker Group Inc. MKGI | Leave a comment